These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 27904879)

  • 21. Neisseria meningitidis serogroup W, Burkina Faso, 2012.
    MacNeil JR; Medah I; Koussoubé D; Novak RT; Cohn AC; Diomandé FV; Yelbeogo D; Kambou JL; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Hatcher C; Vuong J; Mayer LW; Djingarey MH; Clark TA; Messonnier NE
    Emerg Infect Dis; 2014 Mar; 20(3):394-9. PubMed ID: 24571805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
    Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA
    Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of
    Lemos APS; Gorla MCO; de Moraes C; Willemann MC; Sacchi CT; Fukasawa LO; Camargo CH; Barreto G; Rodrigues DS; Gonçalves MG; Higa FT; Salgado MM; de Moraes JC
    J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35144719
    [No Abstract]   [Full Text] [Related]  

  • 25. Invasive Meningococcal Disease in Africa's Meningitis Belt: More Than Just Meningitis?
    Reese HE; Ronveaux O; Mwenda JM; Bita A; Cohen AL; Novak RT; Fox LM; Soeters HM
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S263-S265. PubMed ID: 31671435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.
    Lucidarme J; Hill DM; Bratcher HB; Gray SJ; du Plessis M; Tsang RS; Vazquez JA; Taha MK; Ceyhan M; Efron AM; Gorla MC; Findlow J; Jolley KA; Maiden MC; Borrow R
    J Infect; 2015 Nov; 71(5):544-52. PubMed ID: 26226598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [From genomics to surveillance, prevention and control: new challenges for the African meningitis belt].
    Alonso JM; Bertherat E; Perea W; Borrow R; Chanteau S; Cohet C; Dodet B; Greenwood B; LaForce FM; Muros-Le Rouzic E; Teyssou R; Ouédraogo-Traoré R; Sow I
    Bull Soc Pathol Exot; 2006 Dec; 99(5):404-8. PubMed ID: 17253061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.
    Mounkoro D; Nikiema CS; Maman I; Sakandé S; Bozio CH; Tall H; Sadji AY; Njanpop-Lafourcade BM; Sibabe A; Landoh DE; Abodji EO; Kodjo A; Tamekloe TA; Essoh TA; Maba DW; Gessner BD; Moïsi JC
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S216-S224. PubMed ID: 31671438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.
    Yezli S
    Travel Med Infect Dis; 2018; 24():51-58. PubMed ID: 29751133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis.
    Mustapha MM; Marsh JW; Krauland MG; Fernandez JO; de Lemos AP; Dunning Hotopp JC; Wang X; Mayer LW; Lawrence JG; Hiller NL; Harrison LH
    EBioMedicine; 2015 Oct; 2(10):1447-55. PubMed ID: 26629539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.
    Norheim G; Tunheim G; Næss LM; Kristiansen PA; Caugant DA; Rosenqvist E
    Scand J Immunol; 2012 Aug; 76(2):99-107. PubMed ID: 22537024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.
    Knol MJ; Hahné SJM; Lucidarme J; Campbell H; de Melker HE; Gray SJ; Borrow R; Ladhani SN; Ramsay ME; van der Ende A
    Lancet Public Health; 2017 Oct; 2(10):e473-e482. PubMed ID: 29253430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
    Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningitis epidemics in Africa: a brief overview.
    Teyssou R; Muros-Le Rouzic E
    Vaccine; 2007 Sep; 25 Suppl 1():A3-7. PubMed ID: 17643560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001.
    Ouedraogo-Traore R; Høiby EA; Sanou I; Sangare L; Kyelem N; Ye-Ouattara D; Frøholm LO; Caugant DA
    Scand J Infect Dis; 2002; 34(11):804-7. PubMed ID: 12578146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
    Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
    Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.
    Diallo K; Gamougam K; Daugla DM; Harrison OB; Bray JE; Caugant DA; Lucidarme J; Trotter CL; Hassan-King M; Stuart JM; Manigart O; Greenwood BM; Maiden MCJ
    BMC Genomics; 2017 May; 18(1):398. PubMed ID: 28532434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
    Sidikou F; Zaneidou M; Alkassoum I; Schwartz S; Issaka B; Obama R; Lingani C; Tate A; Ake F; Sakande S; Ousmane S; Zanguina J; Seidou I; Nzeyimana I; Mounkoro D; Abodji O; Wang X; Taha MK; Moulia-Pelat JP; Pana A; Kadade G; Ronveaux O; Novak R; Oukem-Boyer OOM; Meyer S;
    Lancet Infect Dis; 2016 Nov; 16(11):1288-1294. PubMed ID: 27567107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA).
    Koeberling O; Ispasanie E; Hauser J; Rossi O; Pluschke G; Caugant DA; Saul A; MacLennan CA
    Vaccine; 2014 May; 32(23):2688-95. PubMed ID: 24704334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.